25.47
0.12%
0.03
시간 외 거래:
25.68
0.21
+0.82%
전일 마감가:
$25.44
열려 있는:
$25.44
하루 거래량:
189.07K
Relative Volume:
2.97
시가총액:
$1.36B
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-0.24%
1개월 성능:
+0.00%
6개월 성능:
+0.00%
1년 성능:
+0.00%
Bicara Therapeutics Inc Stock (BCAX) Company Profile
Bicara Therapeutics Inc 주식(BCAX)의 최신 뉴스
Bicara Therapeutics, Adecoagro, and More Stocks See Action From Activist Investors - Barron's
With IPO, have the capital and resources for clinical studies: Bicara CEO - The Economic Times
Bicara Therapeutics Rings the Opening Bell - Nasdaq
Biotech IPO Shares Climb in Debuts After Deals Upsized - MSN
TPG GP A, LLC Acquires New Stake in Bicara Therapeutics Inc - GuruFocus.com
James E. Flynn Buys 70,000 Shares of Bicara Therapeutics Inc. (NASDAQ:BCAX) Stock - Defense World
Ra Capital Management, L.P. Purchases 1,833,000 Shares of Bicara Therapeutics Inc. (NASDAQ:BCAX) Stock - Defense World
Ra capital executives buy Bicara Therapeutics shares for $32.99m By Investing.com - Investing.com Canada
Ra capital executives buy Bicara Therapeutics shares for $32.99m - Investing.com India
Ra capital executives buy Bicara Therapeutics shares for $32.99m - Investing.com
Ra capital executives buy Bicara Therapeutics shares for $32.99m By Investing.com - Investing.com UK
FMR LLC Acquires New Stake in Bicara Therapeutics Inc - Yahoo Finance
FMR LLC Acquires New Stake in Bicara Therapeutics Inc - GuruFocus.com
Bicara Leads Trio of US Biotech IPOs Raising $703 Million - MSN
Deerfield entities buy Bicara Therapeutics shares worth $1.26m By Investing.com - Investing.com Australia
Deerfield entities buy Bicara Therapeutics shares worth $1.26m - Investing.com
Bicara Therapeutics closes $362m IPO in flurry of biotech listing activity - Yahoo Finance
Bicara Therapeutics closes $362m IPO in flurry of biotech listing activity - Pharmaceutical Technology
MBX, Zenas And Bicara IPOs Generate Big First Day Returns, But Will They Last? - Scrip
Bicara Therapeutics Announces Closing of $362 Million - GlobeNewswire
Bicara Therapeutics Announces Closing of $362 Million Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares - StockTitan
Bicara, MBX Bio lead gainers as biotech trio makes trading debut - MSN
TPG-backed Bicara Therapeutics shares surge 46% in stellar market debut - MSN
Biotech IPOs Surge on Debut: Upsized Deals Boost Shares for Drug Developers Tackling Autoimmune Diseases - Share Price India News
Trio of first-day pops may bode well for biotech IPO window - BioCentury
Bicara Therapeutics Opens at $26.25 , Upsized IPO Priced at $18 By Investing.com - Investing.com Canada
Biotech IPO Shares Climb in Debuts After Deals Upsized - Bloomberg
2 Life Sciences Cos. Start Trading After Raising $540M Total - Law360
TPG-backed Bicara Therapeutics shares surge 46% in stellar market debut - KFGO
Bicara Therapeutics Rises 39% in Debut on Nasdaq - MarketWatch
3 Biotech IPOs, $703M Raised for Clinical Trials in Cancer, Immunology & Endocrine Disorders - MedCity News
Shares of two Mass. biotech IPOs rise on first day of trading - The Business Journals
Bicara, MBX Bio lead gainers among biotech IPOs (NASDAQ:BCAX) - Seeking Alpha
TPG-backed Bicara Therapeutics shares surge 46% in stellar market debut - Reuters
Biotech IPO Shares Climb in Debuts After Deals Upsized - BNN Bloomberg
TPG-backed Bicara Therapeutics shares surge 46% in stellar market debut - WDKE 96.1 Duke FM
TPG-backed Bicara Therapeutics raises $315 mln in US IPO - Reuters
Two local biotechs go public, raising $540 million total - The Boston Globe
3 Biotechs Seek Over $700M in Renewed IPO Rush - BioSpace
Two local biotechs pull in $540M in IPOs - The Business Journals
Bicara Leads Trio of US Biotech IPOs Raising $703 Million - Yahoo Finance
Bicara Leads Trio of US Biotech IPOs Raising $703 Million - Bloomberg
Three biotechs raise $700M in rare burst of IPO activity - BioPharma Dive
Bicara Therapeutics Announces Pricing of Upsized Initial Public Offering - ForexTV.com
BCAXBicara Therapeutics Inc. Latest Stock News & Market Updates - StockTitan
Bicara Therapeutics Announces Pricing of Upsized Initial Public Offering - StockTitan
Bicara Therapeutics Announces Pricing Of Upsized Initial Public Offering - XM
Bicara Therapeutics Announces Pricing of Upsized Initial Public Offering - GlobeNewswire
Three biotechs raise $700M in rare burst of IPO activity - Yahoo Finance
Boston biotech increases target for pending IPO - The Business Journals
Bicara Therapeutics targets $265 million proceeds in upsized US IPO - KFGO
Bicara Therapeutics Inc (BCAX) 재무 분석
Bicara Therapeutics Inc (BCAX)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):